TARO News and Press, Taro Pharmaceutical Industries Ltd. From 10/26/23

2023-10-26 17:07:56 ET Taro Pharmaceutical press release ( NYSE: TARO ): Q2 GAAP EPS of $0.23. Revenue of $148.2M (+13.6% Y/Y). Research and development (R&D) expenses of $14.3 million increased $2.8 million, principally the result of increased clinical studies. ...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and six months ended September 30, 2023. Quarter ended September 30, 2023 Highlights ─ compared to September 30, 2022 ...

CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...

Taro Pharmaceutical Industries Ltd. (TARO) is expected to report $0.18 for Q2 2024

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the second quarter ended September 30, 2023, after the close of market on Thursday, October 26, 2023. The release will be accessible on Taro’s website at www.taro.com ...

2023-08-16 06:25:15 ET Summary Taro Pharmaceutical's minority shareholders have resisted Sun Pharmaceuticals' offer of $38 per share, stating that Taro is worth more. Taro's operating economics are unattractive in my view, with declining pre-tax earnings and no revenue growth. ...

2023-07-27 05:45:35 ET Taro Pharmaceutical press release ( NYSE: TARO ): Q2 Non-GAAP EPS of $0.40 beats by $0.09 . Revenue of $158.9M (+1.4% Y/Y) beats by $9.87M . For further details see: Taro Pharmaceutical Non-GAAP EPS of $0.40 beats by $0.09, revenue ...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2023. Quarter ended June 30, 2023 Highlights ─ compared to June 30, 2022 Net sales increased $2.2 m...

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the first quarter ended June 30, 2023, after the close of market on Wednesday, July 26, 2023. The release will be accessible on Taro’s website at www.taro.com . ...

Krensavage Asset Management Opposes Sun's Lowball Bid for Taro PR Newswire NEW YORK , July 19, 2023 /PRNewswire/ -- As the largest minority shareholder 1 of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Krensavage Asset Management LLC opposes Sun Pharmace...